Camp4 Therapeutics GAAP EPS of -$0.62 beats by $0.06, revenue of $1.5M beats by $1.2M

* Camp4 Therapeutics press release [https://seekingalpha.com/pr/20201852-camp4-reports-second-quarter-2025-financial-results-and-corporate-highlights] (NASDAQ:CAMP [https://seekingalpha.com/symbol/CAMP]): Q2 GAAP EPS of -$0.62 beats by $0.06.
* Revenue of $1.5M beats by $1.2M.
* Cash, cash equivalents, and marketable securities as of June 30, 2025, were $39.1 million, compared to $49.3 million as of March 31, 2025.

MORE ON CAMP4 THERAPEUTICS

* Historical earnings data for Camp4 Therapeutics [https://seekingalpha.com/symbol/CAMP/earnings]
* Financial information for Camp4 Therapeutics [https://seekingalpha.com/symbol/CAMP/income-statement]